Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Rowland

Showing results (51-60 of 184) with videos related to

Pageof 19
Sort By:
Frontiers in Pharmacology|January 14, 2017
Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and <i>In silico</i> Assessment of Metabolic Drug-Drug Interactions Involving ModafinilAngela Rowland, Arduino A Mangoni, Ashley Hopkins, et al.
British Journal of Clinical Pharmacology|July 30, 2024
Establishing the capacity to monitor proteins relevant to the study of drug exposure and response using liver-derived extracellular vesiclesLauren A Newman, Zivile Useckaite, Ting Wu, et al.
Biochemical Pharmacology|August 25, 2019
Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202Porntipa Korprasertthaworn, Nuy Chau, Pramod C Nair, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 13, 2023
Analysis of Extracellular Vesicle and Contaminant Markers in Blood Derivatives Using Multiple Reaction MonitoringLauren A Newman, Zivile Useckaite, Ting Wu, et al.
Microorganisms|January 25, 2025
Antibacterial Potential of Crude Extracts from <i>Cylindrospermum alatosporum</i> NR125682 and <i>Loriellopsis cavernicola</i> NR117881Albert Olufemi Ikhane, Foluso Oluwagbemiga Osunsanmi, Rebamang Anthony Mosa, et al.
BMC Cancer|February 28, 2020
Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trialsAshley M Hopkins, Akash D Rathod, Andrew Rowland, et al.
Pharmacology & Therapeutics|June 1, 2023
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significanceJohn O Miners, Thomas M Polasek, Julie-Ann Hulin, et al.
International Journal of Cancer|December 22, 2015
Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trialsMichael J Sorich, Ganessan Kichenadasse, Andrew Rowland, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2013
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosisMichael D Wiese, Andrew Rowland, Thomas M Polasek, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 14, 2016
A novel approach for the simultaneous quantification of 18 small molecule kinase inhibitors in human plasma: A platform for optimised KI dosingMadelé van Dyk, John O Miners, Ganessan Kichenadasse, et al.
Pageof 19

Showing results (51-60 of 184) with videos related to

Sort By:
Pageof 19
Frontiers in Pharmacology|January 14, 2017
Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and <i>In silico</i> Assessment of Metabolic Drug-Drug Interactions Involving ModafinilAngela Rowland, Arduino A Mangoni, Ashley Hopkins, et al.
British Journal of Clinical Pharmacology|July 30, 2024
Establishing the capacity to monitor proteins relevant to the study of drug exposure and response using liver-derived extracellular vesiclesLauren A Newman, Zivile Useckaite, Ting Wu, et al.
Biochemical Pharmacology|August 25, 2019
Inhibition of human UDP-glucuronosyltransferase (UGT) enzymes by kinase inhibitors: Effects of dabrafenib, ibrutinib, nintedanib, trametinib and BIBF 1202Porntipa Korprasertthaworn, Nuy Chau, Pramod C Nair, et al.
Methods in Molecular Biology (Clifton, N.J.)|February 13, 2023
Analysis of Extracellular Vesicle and Contaminant Markers in Blood Derivatives Using Multiple Reaction MonitoringLauren A Newman, Zivile Useckaite, Ting Wu, et al.
Microorganisms|January 25, 2025
Antibacterial Potential of Crude Extracts from <i>Cylindrospermum alatosporum</i> NR125682 and <i>Loriellopsis cavernicola</i> NR117881Albert Olufemi Ikhane, Foluso Oluwagbemiga Osunsanmi, Rebamang Anthony Mosa, et al.
BMC Cancer|February 28, 2020
Risk factors for severe rash with use of vemurafenib alone or in combination with cobimetinib for advanced melanoma: pooled analysis of clinical trialsAshley M Hopkins, Akash D Rathod, Andrew Rowland, et al.
Pharmacology & Therapeutics|June 1, 2023
Drug-drug interactions that alter the exposure of glucuronidated drugs: Scope, UDP-glucuronosyltransferase (UGT) enzyme selectivity, mechanisms (inhibition and induction), and clinical significanceJohn O Miners, Thomas M Polasek, Julie-Ann Hulin, et al.
International Journal of Cancer|December 22, 2015
Angiotensin system inhibitors and survival in patients with metastatic renal cell carcinoma treated with VEGF-targeted therapy: A pooled secondary analysis of clinical trialsMichael J Sorich, Ganessan Kichenadasse, Andrew Rowland, et al.
Expert Opinion on Drug Metabolism & Toxicology|May 21, 2013
Pharmacokinetic evaluation of teriflunomide for the treatment of multiple sclerosisMichael D Wiese, Andrew Rowland, Thomas M Polasek, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|August 14, 2016
A novel approach for the simultaneous quantification of 18 small molecule kinase inhibitors in human plasma: A platform for optimised KI dosingMadelé van Dyk, John O Miners, Ganessan Kichenadasse, et al.
Pageof 19